Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Prospective, Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Combination of Focused Ultrasound With Re-irradiation for the Treatment Patients With Recurrent Glioblastoma Multiforme Using NaviFUS System

NCT04988750 is registered in ClinicalTrials.gov with NaviFUS Corporation as lead sponsor.

NCT NCT04988750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04988750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Prospective, Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Combination of Focused Ultrasound With Re-irradiation for the Treatment Patients With Recurrent Glioblastoma Multiforme Using NaviFUS System
Lead sponsor
NaviFUS Corporation
Phase
Not applicable
Overall status
Completed
Start date
May 23, 2021
Completion date
June 16, 2025
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor adult, brain tumor recurrent, brain tumor, adult: glioblastoma, brain tumor, recurrent, high-grade glioma (who iii-iv), recurrent glioblastoma